Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

21.73
+0.49002.31%
Post-market: 21.730.00000.00%16:32 EST
Volume:710.87K
Turnover:15.36M
Market Cap:893.10M
PE:46.11
High:22.02
Open:21.28
Low:20.88
Close:21.24
52wk High:27.64
52wk Low:18.80
Shares:41.10M
Float Shares:37.84M
Volume Ratio:1.11
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4713
EPS(LYR):-2.1529
ROE:2.90%
ROA:2.89%
PB:1.23
PE(LYR):-10.09

Loading ...

Company Profile

Company Name:
Pacira Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
2006
Employees:
789
Office Location:
2000 Sierra Point Parkway,Suite 900,Brisbane,California,United States
Zip Code:
94005
Fax:
- -
Introduction:
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Directors

Name
Position
Frank D. Lee
Director and Chief Executive Officer
Abraham Ceesay
Independent Director
Alethia Young
Independent Director
Christopher Christie
Independent Director
Laura Brege
Independent Board Chair
Marcelo Bigal
Independent Director
Mark A. Kronenfeld
Independent Director
Mark I. Froimson
Independent Director
Michael Yang
Independent Director
Samit Hirawat
Director

Shareholders

Name
Position
Frank D. Lee
Director and Chief Executive Officer
Shawn Cross
Chief Financial Officer
Brendan Teehan
Chief Commercial Officer
Jonathan Slonin
Chief Medical Officer
Kristen Williams
Chief Administrative Officer and Secretary